Gold, J; Marta, M; Meier, UC; Christensen, T; Miller, D; Altmann, D; Holden, D; ... Giovannoni, G; + view all (2018) A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study. Multiple Sclerosis and Related Disorders , 24 pp. 123-128. 10.1016/j.msard.2018.06.002. Green open access